Reuters logo
3 个月前
BRIEF-Neurocrine Biosciences reports Q1 loss per share $0.90
2017年5月9日 / 晚上8点49分 / 3 个月前

BRIEF-Neurocrine Biosciences reports Q1 loss per share $0.90

May 9 (Reuters) - Neurocrine Biosciences Inc

* Neurocrine Biosciences reports first quarter 2017 results

* Q1 loss per share $0.90

* Q1 earnings per share view $-0.74 -- Thomson Reuters I/B/E/S

* Neurocrine Biosciences Inc says did not report any revenue for Q1 of 2017 compared to $15.0 million of revenue for Q1 of 2016

* Neurocrine Biosciences Inc says intends to meet with FDA in late 2017 to discuss a potential new drug application submission

* Neurocrine Biosciences -Enrolled subjects in a Phase I safety and pharmacokinetics study exploring NBI-74788 in healthy volunteers that is nearing completion Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below